Fuhrmann U

No ORCID on file · 7 papers in corpus
article 2014
Human Reproduction ·doi:10.1093/humrep/deu315

Is it feasible to deliver anastrozole (ATZ), an aromatase inhibitor (AI), by a vaginal polymer-based drug delivery system in the cynomolgus monkey (Macaca fascicularis) to describe the pharmacokinetic profile? The present study showed the e…

article 2012
Expert opinion on therapeutic targets ·doi:10.1517/14728222.2012.661415

Endometriosis (EMS) is a chronic, estrogen-dependent inflammatory disease characterized by growth of endometrial tissue outside the uterine cavity. Symptoms in EMS patients include severe pelvic pain, dysmenorrhea, dyspareunia and infertili…

article 2012
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719112451147

We identified differentially expressed genes comparing peritoneal endometriosis lesions (n = 18), eutopic endometrium (n = 17), and peritoneum (n = 22) from the same patients with complete menstrual cycles using microarrays (54 675 probe se…

article 2011
Gynecologic and obstetric investigation ·doi:10.1159/000331642

BACKGROUND: Dienogest demonstrates efficacy for lesion reduction and pain relief in clinical trials of endometriosis. The current study investigated an intraperitoneal animal model of endometriosis to further characterize the effects of die…

other 2009
The Journal of steroid biochemistry and molecular biology ·doi:10.1016/j.jsbmb.2008.11.015

Progesterone receptor modulators (PRMs) play an important role in women's health. They are widely used in oral contraception or hormone therapy, and provide an attractive treatment approach for gynecological disorders such as uterine leiomy…

article 2008
Human Reproduction ·doi:10.1093/humrep/den189

BACKGROUND: The role of the immune system in the pathogenesis of endometriosis remains elusive. It has been shown that patients have an altered peritoneal environment with increased levels of inflammatory cytokines, activated macrophages an…

other 2000
Journal of medicinal chemistry ·doi:10.1021/jm001000c

Herein we describe the chemical synthesis and pharmacological characterization of a novel, highly potent progesterone receptor (PR) antagonist, ZK 230211. The introduction of a 17alpha-pentafluorethyl side chain in the D-ring of the steroid…